RecruitingEarly Phase 1NCT05343572
Bone Marrow Derived Stem Cells Mobilization for Treatment of Abnormal Endometrium
Studying Asherman syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Hugh Taylor
- Principal Investigator
- Hugh Taylor, MDYale University
- Intervention
- Plerixafor(drug)
- Enrollment
- 90 enrolled
- Eligibility
- 18-40 years · FEMALE
- Timeline
- 2023 – 2027
Study locations (1)
- Yale Fertility Center, Orange, Connecticut, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05343572 on ClinicalTrials.govOther trials for Asherman syndrome
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNANCT06608407Platelet Rich Plasma in the Prevention of Adhesion ReformationFu Xing Hospital, Capital Medical University
- ACTIVE NOT RECRUITINGNANCT04963179PREvention of Intrauterine Adhesion After Adhesiolysis With Novel Tri-block deGradable Polymer Film.Womed
- RECRUITINGPHASE4NCT04671914Prevalence of Intrauterine Adhesions After D&C With or Without Antiadhesion Gel After Abortion in Second Trimester.Institute for the Care of Mother and Child, Prague, Czech Republic